Fiche centre
Aversi Clinic Ltd
Tbilisi — Georgia
Essais liés4clinical trials
VilleTbilisilocalisation
PaysGeorgialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03742037
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Cenerimod | Lupus | Phase 3 | NCT05672576 | OPUS-2 — A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus | ACTIVE_NOT_RECRUITING |
| Cenerimod | Lupus | Phase 3 | NCT06475742 | OPUS OLE — Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus | ENROLLING_BY_INVITATION |
| Cenerimod 0.5 mg | Lupus | Phase 2 | NCT03742037 | Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus | COMPLETED |
| Cladribine Low Dose | Myasthénie | Phase 3 | NCT06463587 | Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) | RECRUITING |